Protalix BioTherapeutics Inc/ US74365A1016 /
| 7/5/2022 4:59:13 PM | Chg. -0.01 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.07USD | -0.47% | 100 Turnover: 107 |
-Bid Size: - | -Ask Size: - | 1.07 | 1.07 |
GlobeNewswire
8/2/2021
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cG...
GlobeNewswire
6/8/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTher...
GlobeNewswire
2/2/2021
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its B...
GlobeNewswire
10/2/2020
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Launch of Expanded Access Program ...
GlobeNewswire
2/20/2020
Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Med...
GlobeNewswire
8/30/2019
Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American
GlobeNewswire
8/22/2019
Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Val...
GlobeNewswire
8/8/2019
Protalix BioTherapeutics Reports Second Quarter 2019 Results and Provides Corporate Update
GlobeNewswire
7/29/2019
Protalix BioTherapeutics to Hold Second Quarter 2019 Financial Results and Corporate Update Conferen...
GlobeNewswire
7/29/2019
Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Of...
GlobeNewswire
7/17/2019
Global Fabry Disease Treatment Market Review 2017-2019 & Forecast to 2025 - Focus on Enzyme Replacem...
GlobeNewswire
6/17/2019
Protalix BioTherapeutics Completes Enrollment in the Phase III BRIGHT Clinical Trial of pegunigalsid...
GlobeNewswire
6/6/2019
Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of peguniga...
GlobeNewswire
5/21/2019
Protalix BioTherapeutics Appoints Dror Bashan as its New President and Chief Executive Officer and D...
GlobeNewswire
5/6/2019
Protalix BioTherapeutics Reports 2019 First Quarter Results and Provides Corporate Update
GlobeNewswire
4/29/2019
Protalix BioTherapeutics to Hold First Quarter 2019 Financial Results and Corporate Update Conferenc...
GlobeNewswire
4/12/2019
Research Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, Bi...
GlobeNewswire
3/18/2019
Protalix BioTherapeutics Reports 2018 Full Year Results and Provides Corporate Update
GlobeNewswire
3/13/2019
Protalix BioTherapeutics to Postpone the 2018 Financial Results and Corporate Update Conference Call
GlobeNewswire
3/6/2019
Protalix BioTherapeutics to Hold Full-Year 2018 Financial Results and Corporate Update Conference Ca...
GlobeNewswire
2/14/2019
Global Fabry Disease Market Insights, Epidemiology and Market Forecast 2019-2028
GlobeNewswire
2/5/2019
Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for...